CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 8, September 2013
338
AFRICA
WM,
et al.
European Guidelines on cardiovascular disease prevention
in clinical practice (version 2012): The Fifth Joint Task Force of the
European Society of Cardiology and Other Societies on Cardiovascular
Disease Prevention in Clinical Practice (constituted by representatives
of nine societies and by invited experts).
Atherosclerosis
2012;
223
(1):
1–68. PubMed PMID: 22698795. Epub 2012/06/16. eng.
23. Grundy SM, Cleeman JI, Merz CN, Brewer HB, Jr., Clark LT,
Hunninghake DB,
et al.
Implications of recent clinical trials for
the National Cholesterol Education Program Adult Treatment Panel
III guidelines.
Circulation
2004;
110
(2): 227–239. PubMed PMID:
15249516. Epub 2004/07/14. eng.
24. Gitt AK, Drexel H, Feely J, Ferrieres J, Gonzalez-Juanatey JR, Thomsen
KK,
et al.
Persistent lipid abnormalities in statin-treated patients and
predictors of LDL-cholesterol goal achievement in clinical practice
in Europe and Canada.
Eur J Prevent Cardiol
2012;
19
(2): 221–30.
PubMed PMID: 21450578. Epub 2011/04/01. eng.
25. Leiter LA, Lundman P, da Silva PM, Drexel H, Junger C, Gitt AK.
Persistent lipid abnormalities in statin-treated patients with diabe-
tes mellitus in Europe and Canada: results of the Dyslipidaemia
International Study.
Diabetic Med
2011;
28
(11): 1343–1351. PubMed
PMID: 21679231. Epub 2011/06/18. eng.
26. Raal F, Schamroth C, Blom D, Marx J, Rajput M, Haus M,
et al
.
CEPHEUS SA: a South African survey on the undertreatment of hyper-
cholesterolaemia.
Cardiovasc J Afr
2011;
22
(5): 234–240. PubMed
PMID: 21922121.
27. Roberts WC. The rule of 5 and the rule of 7 in lipid-lowering by statin
drugs.
Am J Cardiol
1997;
80
(1): 106–107. PubMed PMID: 9205036.
Epub 1997/07/01. eng.
28. CatapanoAL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund
O,
et al
. ESC/EAS Guidelines for the management of dyslipidaemias,
the Task Force for the management of dyslipidaemias of the European
Society of Cardiology (ESC) and the European Atherosclerosis Society
(EAS).
Atherosclerosis
2011;
217
(1): 3–46. PubMed PMID: 21882396.
Epub 2011/09/02. eng.
29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin
BA,
et al
. Diagnosis and management of the metabolic syndrome: an
American Heart Association/National Heart, Lung, and Blood Institute
scientific statement: executive summary.
Crit Pathways Cardiol
2005;
4
(4): 198–203. PubMed PMID: 18340209.
30. Al Sifri SN, Almahmeed W, Azar S, Okkeh O, Bramlage P, Jünger C,
et al
. Results of the Dyslipidemia International Study (DYSIS)-Middle
East: a clinical perspective on the prevalence and characteristics of lipid
abnormalities in the setting of chronic statin treatment. In press 2013.
31. Hempler NF, Diderichsen F, Larsen FB, Ladelund S, Jorgensen T. Do
immigrants from Turkey, Pakistan and Yugoslavia receive adequate
medical treatment with beta-blockers and statins after acute myocar-
dial infarction compared with Danish-born residents? A register-based
follow-up study.
Eur J Clin Pharmac
2010;
66
(7): 735–742. PubMed
PMID: 20393695.
32. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J,
et al
.
Patient, physician, and payment predictors of statin adherence.
Med
Care
2010;
48
(3): 196–202. PubMed PMID: 19890219.
33. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian
U. Adherence to cardiovascular disease medications: does patient-
provider race/ethnicity and language concordance matter?
J Gen Int
Med
2010;
25
(11): 1172–1177. PubMed PMID: 20571929. Pubmed
Central PMCID: 2947630.
34. Sliwa K, Lyons JG, Carrington MJ, Lecour S, Marais AD, Raal FJ,
et
al.
Different lipid profiles according to ethnicity in the Heart of Soweto
study cohort of de novo presentations of heart disease.
Cardiovasc J Afr
2012;
23
(7): 389–395. PubMed PMID: 22914997.
35. Kotseva K, Stagmo M, De Bacquer D, De Backer G, Wood D. Treatment
potential for cholesterol management in patients with coronary heart
disease in 15 European countries: findings from the EUROASPIRE
II survey.
Atherosclerosis
2008;
197
(2): 710–717. PubMed PMID:
17765905. Epub 2007/09/04. eng.
36. Sudano I, Hess L, Noll G, Arnet D. Persistent dyslipidemia in statin-
treated patients: the focus on comprehensive lipid management survey
in Swiss patients.
Swiss Med Weekly
2011;
141
: w13200. PubMed
PMID: 21574067. Epub 2011/05/17. eng.
37. Eber B, Lautsch D, Fauer C, Drexel H, Pfeiffer KP, Traindl O,
et al
.
Can LDL-cholesterol targets be achieved in a population at high risk?
Results of the non-interventional study ACT II.
Curr Med Res Opin
2012;
28
(9): 1447–1454. PubMed PMID: 22856551. Epub 2012/08/04.
eng.
38. Bandgar TR, Faruqui AA. Managing dyslipidaemia: evolving role
of combination therapy.
J Indian Med Assoc
2011;
109
(8): 549–552.
PubMed PMID: 22315861. Epub 2012/02/10. eng.
39. Ito MK. Dyslipidemia: management using optimal lipid-lowering
therapy.
Ann Pharmacother
2012;
46
(10): 1368–1381. PubMed PMID:
23032652. Epub 2012/10/04. eng.
40. Schedlbauer A, Davies P, Fahey T. Interventions to improve adherence
to lipid lowering medication.
Cochrane Database Syst Rev
2010 (3):
CD004371. PubMed PMID: 20238331.
41. Dragomir A, Cote R, White M, Lalonde L, Blais L, Berard A,
et al.
Relationship between adherence level to statins, clinical issues and
health-care costs in real-life clinical setting.
Value Health
2010;
13
(1):
87–94. PubMed PMID: 19695008.
42. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson
PN,
et al.
Medication nonadherence is associated with a broad range of
adverse outcomes in patients with coronary artery disease.
Am Heart J
2008;
155
(4): 772–779. PubMed PMID: 18371492.
43. McGinnis BD, Olson KL, Delate TM, Stolcpart RS. Statin adher-
ence and mortality in patients enrolled in a secondary prevention
program.
Am J Managed Care
2009;
15
(10): 689–695. PubMed PMID:
19845421.
44. Wei L, Fahey T, MacDonald TM. Adherence to statin or aspirin or both
in patients with established cardiovascular disease: exploring healthy
behaviour vs. drug effects and 10-year follow-up of outcome.
Br J Clin
Pharmacol
2008;
66
(1): 110–116. PubMed PMID: 18492127. Pubmed
Central PMCID: 2485263.
45. Shroufi A, Powles JW. Adherence and chemoprevention in major
cardiovascular disease: a simulation study of the benefits of additional
use of statins.
J Epidemiol Commun Health
2010;
64
(2): 109–113.
PubMed PMID: 20056964.
46. Wierzbicki AS, Hardman TC, Viljoen A. New lipid-lowering drugs:
an update.
Int J Clin Pract
2012;
66
(3): 270–280. PubMed PMID:
22340447.
